RA
GILD icon

Rise Advisors’s Gilead Sciences GILD Stock Holding History

Rise Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-812
Closed -$90.1K – 635
2025
Q3 		$90.1K Buy
812
+27
+3% +$3.07K 0.03% 171
2025
Q2 		$87K Buy
785
+2
+0.3% +$213 0.03% 170
2025
Q1 		$87.8K Buy
783
+16
+2% +$1.65K 0.04% 160
2024
Q4 		$70.9K Sell
767
-24
-3% -$2.16K 0.03% 176
2024
Q3 		$66.4K Buy
791
+37
+5% +$2.82K 0.03% 194
2024
Q2 		$51.7K Buy
754
+8
+1% +$534 0.03% 232
2024
Q1 		$54.6K Buy
746
+203
+37% +$15.6K 0.03% 217
2023
Q4 		$44K Buy
543
+162
+43% +$12.6K 0.03% 172
2023
Q3 		$28.6K Sell
381
-44
-10% -$3.38K 0.02% 194
2023
Q2 		$32.7K Sell
425
-25
-6% -$1.99K 0.03% 191
2023
Q1 		$37.3K Buy
450
+8
+2% +$663 0.03% 182
2022
Q4 		$38K Buy
442
+48
+12% +$3.8K 0.03% 177
2022
Q3 		$24K Buy
394
+4
+1% +$252 0.02% 219
2022
Q2 		$24K Buy
390
+298
+324% +$18.4K 0.02% 212
2022
Q1 		$5K Buy
92
+1
+1% +$64 ﹤0.01% 421
2021
Q4 		$6.62K Buy
+91
New +$6.27K 0.01% 373

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Rise Advisors's GILD Position: Q4 2025 in Review

Rise Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 812 shares — an estimated $90.1K sold.

Rise Advisors first reported a position in GILD in Q4 2021 and held it in 16 quarters. The position peaked at $90.1K in Q3 2025. 2,228 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Rise Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 812 Gilead Sciences shares in Q4 2025, an estimated $90.1K.
  • Rise Advisors first reported a position in Gilead Sciences in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Gilead Sciences position peaked at $90.1K in Q3 2025.
  • 2,228 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.